Items where authors include "Peckham, D.G."

Article

Calthorpe, R.J., Saumtally, H.A., Howells, L.M. et al. (13 more authors) (2025) CF Tummy Tracker: A Cystic Fibrosis-Specific Patient Reported Outcome Measure for Daily Gastrointestinal Symptom Burden. Mayo Clinic Proceedings Digital Health. 100203. ISSN 2949-7612

Caley, L.R. orcid.org/0000-0001-8957-1018, Gillgrass, L., Zagoya, C. et al. (5 more authors) (2025) Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. Journal of Cystic Fibrosis. ISSN 1569-1993

Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Caley, L.R. orcid.org/0000-0001-8957-1018, Lara-Reyna, S. et al. (4 more authors) (2024) Heightened mitochondrial respiration in CF cells is normalised by triple CFTR modulator therapy through mechanisms involving calcium. Heliyon, 10 (20). e39244. ISSN 1879-4378

Smith, C., Chadwick, H.K. orcid.org/0000-0002-8022-5490, Hill, K. et al. (2 more authors) (2024) E-learning within the European cystic fibrosis society - A multidisciplinary cross-sectional survey. Journal of Cystic Fibrosis. ISSN 1569-1993

Caley, L.R. orcid.org/0000-0001-8957-1018, Wood, H.M. orcid.org/0000-0003-3009-5904, Bottomley, D. orcid.org/0009-0000-5749-2710 et al. (9 more authors) (2024) The gut microbiota in adults with cystic fibrosis compared to colorectal cancer. Journal of Cystic Fibrosis, 23 (2). pp. 262-268. ISSN 1569-1993

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Smith, L. orcid.org/0000-0002-4280-6323 et al. (11 more authors) (2023) Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 22 (6). pp. 1002-1009. ISSN 1569-1993

King, L., White, H., Clifton, I. et al. (3 more authors) (2021) Nutritional status and intake in patients with non-cystic fibrosis bronchiectasis (NCFB) - a cross sectional study. Clinical Nutrition, 40 (9). pp. 5162-5168. ISSN 0261-5614

Flume, P.A., Biner, R.F., Downey, D.G. et al. (190 more authors) (2021) Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. The Lancet Respiratory Medicine, 9 (7). pp. 733-746. ISSN 2213-2600

Spoletini, G. orcid.org/0000-0002-5462-0083, Watson, R., Lim, W.Y. et al. (4 more authors) (2021) Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial. Journal of Cystic Fibrosis, 20 (5). e46-e52. ISSN 1569-1993

Spoletini, G. orcid.org/0000-0002-5462-0083, Pollard, K., Watson, R. et al. (6 more authors) (2021) Noninvasive Ventilation in Cystic Fibrosis: Clinical Indications and Outcomes in a Large UK Adult Cystic Fibrosis Center. Respiratory Care, 66 (3). pp. 466-474. ISSN 0020-1324

Clifton, I.J., Fletcher, L.A., Beggs, C.B. et al. (2 more authors) (2008) A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. BMC Microbiology, 8 (105). ISSN 1471-2180

Proceedings Paper

Jarosz-Griffiths, H.H., Caley, L.R., Lara-Reyna, S. et al. (4 more authors) (2023) EPS3.08 Heightened mitochondrial respiration and succinate levels in cystic fibrosis cells is normalised with triple CFTR modulator therapy through mechanisms involving cell calcium flux. In: Journal of Cystic Fibrosis. European Cystic Fibrosis Conference 2023, 07-10 Jun 2023, Vienna, Austria. Elsevier , s45-s45.

Jarosz-Griffiths, H.H., Caley, L.R., Lara-Reyna, S. et al. (4 more authors) EPS3.08 Heightened mitochondrial respiration and succinate levels in cystic fibrosis cells is normalised with triple CFTR modulator therapy through mechanisms involving cell calcium flux. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier .